RI-MUHC expands recycling to new heights
Impressive cooperation from research programs brings new success to the RI-MUHC waste recycling and sustainability efforts
Exponential growth - 2024 Summer student research event hits record-breaking numbers
A record number of presenters representing every research program contributed to a day filled with...
Eight RI-MUHC trainees earn 2024 EDI award for academic excellence
The awards for Equity, Diversity and Inclusion in health care research recognize the academic excellence...
Four new clinical trials grants from the CIHR for RI-MUHC researchers
The Government of Canada announced investments in 14 new clinical trials to support Canada’s response to major health threats and bolster the...
McGill, industry, CQDM and Brain Canada collaborate for drug discovery
Novel drug could provide hope to those suffering from neuropathic pain and insomnia
Increasing clinical trial expertise at the RI-MUHC
The RI-MUHC ACT-CTU reports on the realization of its vision for 2024 to build a clinical trials community and strengthen trial capabilities at the RI-MUHC
Annual Clinical Research Day event highlights RI-MUHC services and expertise in clinical trials
The Centre for Innovative Medicine and many other clinical research support teams introduced their skills...
Lucy Gilbert honoured for publication in Gynecologic Oncology
The most cited publication and one of the journal’s most read in 2023
New findings illustrate pathway for screening high-risk individuals for pancreatic cancer
An international collaboration of scientists and healthcare professionals is developing a promising surveillance...
A new hope for men with metastatic prostate cancer
MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine